Evidence of participation of soluble CD14 in the host response to microbial invasion of the amniotic cavity and intra-amniotic inflammation in term and preterm gestations

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 12, Issue 5, 2002, Pages 304-312

  Espinoza, J ^a   Chaiworapongsa, T ^a   Romero, R ^a,d   Gomez, R ^b   Kim, J C ^a   Yoshimatsu, J ^a   Edwin, S ^a   Rathnasabapathy, C ^a   Yoon, B H ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^c Seoul National University   (South Korea)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amniotic fluid; CD14; Endotoxin; Fetal blood; Innate immunity; Intra amniotic inflammation; Lipopolysaccharide; Lipopolysaccharide binding protein; Preterm labour; Toll like receptor

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

AMNIOCENTESIS; AMNIONITIS; ANTIGEN PRESENTATION; ARTICLE; CHILDBIRTH; FEMALE; GESTATIONAL AGE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INTRAUTERINE INFECTION; LABOR; MAJOR CLINICAL STUDY; MICROBIAL CONTAMINATION; MYCOPLASMA; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; UREAPLASMA;

EID: 0036854340     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.12.5.304.312     Document Type: Article

References (71)

1. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553-84
2. Arias F, Rodriquez L, Rayne SC, et al. Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585-91
3. Romero R, Sirtori M, Oyarzun E, et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817-24
4. Romero R, Kadar N, Hobbins JC, et al. Infection and labor: The detection of endotoxin in amniotic fluid. Am J Obstet Gynecol 1987;157:815-19
5. Elin RJ, Hosseini J. Clinical utility of the Limulus amebocyte lysate (LAL) test. Prog Clin Biol Res 1985;189:307-27
6. Romero R, Roslansky P, Oyarzun E, et al. Labor and infection. II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol 1988;158:1044-9
7. Fidel PI Jr, Romero R, Maymon E, et al. Bacteria-induced or bacterial product-induced preterm parturition in mice and rabbits is preceded by a significant fall in serum progesterone concentrations. J Matern Fetal Med 1998;7:222-6
8. Fidel PL Jr, Romero R, Wolf N, et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994;170:1467-75
9. Wright SD, Tobias PS, Ulevitch RJ, et al. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 1989;170:1231-41
10. Ulevitch RJ, Mathison JC, Schumann RR, et al. A new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma 1990;30:S189-92
11. Couturier C, Haeffner-Cavaillon N, Caroff M, et al. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J Immunol 1991;147:1899-904
12. Herrmann W, Ecker D, Quast S, et al. Comparison of procalcitonin, sCD14 and interleukin-6 values in septic patients. Clin Chem Lab Med 2000;38:41-6
13. Gebhard F, Rosch M, Helm M, et al. Is the activity of soluble CD14 enhanced following major trauma? Arch Surg 1997;132:1116-20
14. Kruger C, Schutt C, Obertacke U, et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 1991;85:297-301
15. Egerer K, Feist E, Rohr U, et al. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000;9:614-21
16. Yu S, Nakashima N, Xu BH, et al. Pathological significance of elevated soluble CD14 production in rheumatoicl arthritis: In the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol Int 1998;17:237-43
17. Wuthrich B, Kagi MK, Joller-Jemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992;284:339-42
18. Schopf RE, Dobmeyer J, Dobmeyer T, et al. Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis. Dermatology 1993;186:45-9
19. Juffermans NP, Verbon A, van Deventer SJ, et al. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis 1998;178:1839-42
20. Oesterreicher C, Pfeffel F, Petermann D, et al. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J Hepatol 1995;23:396-402
21. Lien E, Aukrust P, Sundan A, et al. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events. Blood 1998;92:2084-92
22. Haziot A, Chen S, Ferrero E, et al. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988;141:547-52
23. Ziegler-Heitbrock HW, Pechumer H, Petersmann I, et al. CD14 is expressed and functional in human B cells. Eur J Immunol 1994;24:1937-40
24. Iida M, Hirai K, Shinohara S, et al. Lipopolysaccharide primes human basophils for enhanced mediator release: Requirement for plasma co-factor and CD14. Biochem Biophys Res Commun 1994;203:1295-301
25. Okada T, Matsuzaki N, Sawai K, et al. Chorioamnionitis reduces placental endocrine functions: The role of bacterial lipopolysaccharide and superoxide anion. J Endocrinol 1997;155:401-10
26. Sugawara S, Sugiyama A, Nemoto E, et al. Heterogeneous expression and release of CD14 by human gingival fibroblasts: Characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect Immun 1998;66:3043-9
27. Durieux JJ, Vita N, Popescu O, et al. The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes. Eur J Immunol 1994;24:2006-12
28. Labeta MO, Durieux JJ, Fernandez N, et al. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol 1993;23:2144-51
29. Bufler P, Stiegler G, Schuchmann M, et al. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol 1995;25:604-10
30. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991;147:1567-74
31. Romero R, Quintero R, Nores J, et al. Amniotic fluid white blood cell count: A rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991;165:821-30
32. Yoon BH, Yang SH, Jun JK, et al. Maternal blood C-reactive protein, white blood cell count, and temperature in preterm labor: A comparison with amniotic fluid white blood cell count. Obstet Gynecol 1996;87:231-7
33. Caritis SN, Toig G, Heddinger LA, et al. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. Am J Obstet Gynecol 1984;150:7-14
34. Petrie RH. Preterm parturition. Tocolysis using magnesium sulfate. Semin Perinatol 1981;5:266-73
35. Mitchell MD, Edwin S, Romero RJ. Prostaglandin biosynthesis by human decidual cells: Effects of inflammatory mediators. Prostaglandins Leukot Essent Fatty Acids 1990;41:35-8
36. Romero R, Mazor M, Wu YK, et al. Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua. Prostaglandins Leukot Essent Fatty Acids 1989;37:183-6
37. 2 production by human amnion. Obstet Gynecol 1988;71:227-8
38. Gardella C, Hitti J, Martin TR, et al. Amniotic fluid lipopolysaccharide-binding protein and soluble CD14 as mediators of the inflammatory response in preterm labor. Am J Obstet Gynecol 2001;184:1241-8
39. Roos T, Martin TR, Ruzinski JT, et al. Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term. Am J Obstet Gynecol 1997;177:1230-7
40. Blanco A, Solis G, Arranz E, et al. Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria. Acta Paediatr 1996;85:728-32
41. Sampson JE, Theve RP, Blatman RN, et al. Fetal origin of amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol 1997;176:77-81
42. Sundan A, Gullstein-Jahr T, Otterlei M, et al. Soluble CD14 from urine copurifies with a potent inducer of cytokines. Eur J Immunol 1994;24:1779-84
43. Martin TR, Rubenfeld G, Steinberg KP, et al. Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest 1994;105:55S-6S
44. Dubin W, Martin TR, Swoveland P, et al. Asthma and endotoxin: Lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol 1996;270:L736-44
45. Ozenci CC, Korgun ET, Demir R. Immunohistochemical detection of CD45+, CD56+, and CD14+ cells in human decidua during early pregnancy. Early Pregnancy 2001;5:164-75
46. Dziarski R, Tapping RI, Tobias PS. Binding of bacterial peptidoglycan to CD14. J Biol Chem 1998;273:8680-90
47. Kengatharan KM, De Kimpe S, Robson C, et al. Mechanism of gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med 1998;188:305-15
48. Hmama Z, Mey A, Normier G, et al. CD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae. Infect Immun 1994;62:1520-7
49. Espevik T, Otterlei M, Skjak-Braek G, et al. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol 1993;23:255-61
50. Pugin J, Heumann ID, Tomasz A, et al. CD14 is a pattern recognition receptor. Immunity 1994;1:509-16
51. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002;23:301-4
52. Jiang Q, Akashi S, Miyake K, et al. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000;165:3541-4
53. Pugin J, Ulevitch RJ, Tobias PS. Activation of endothelial cells by endotoxin: Direct versus indirect pathways and the role of CD14. Prog Clin Biol Res 1995;392:369-73
54. Striz I, Mio T, Adachi Y, et al. The CD14 molecule participates in regulation of IL-8 and IL-6 release by bronchial epithelial cells, Immunol Lett 1998;62:177-81
55. Loppnow H, Stelter F, Schonbeck U, et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 1995;63:1020-6
56. Tobias PS, Soldau K, Gegner JA, et al. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995;270:10482-8
57. Hailman E, Lichenstein HS, Wurfel MM, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994;179:269-77
58. Vita N, Lefort S, Sozzani P, et al. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. J Immunol 1997;158:3457-62
59. Troelstra A, Giepmans BN, Van Kessel KP, et al. Dual effects of soluble CD14 on LPS priming of neutrophils. J Leukoc Biol 1997;61:173-8
60. Haziot A, Rong GW, Bazil V, et al. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J Immunol 1994;152:5868-76
61. Hailman E, Albers JJ, Wolfbauer G, et al. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem 1996;271:12172-8
62. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 1995;181:1743-54
63. Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002;323:59-72
64. Ferrero E, Jiao D, Tsuberi BZ, et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993;90:2380-4
65. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996;4:407-14
66. Schimke J, Mathison J, Morgiewicz J, et al. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA 1998;95:13875-80
67. Leturcq DJ, Moriarty AM, Talbott G, et al. Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996;98:1533-8
68. Wenneras C, Ave P, Huerre M, et al. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol 2000;164:3214-21
69. Le Roy D, Di Padova F, Adachi Y, et al. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol 2001;167:2759-65
70. Antal-Szalmas P. Evaluation of CD14 in host defence. Eur J Clin Invest 2000;30:167-79
71. Gebhardt DO, Beintema A, Reman FC, et al. The lipoprotein composition of amniotic fluid. Clin Chim Acta 1979;94:93-100